CD-LD IR

DRUG3 trials

Sponsors

Impax Laboratories, LLC

Conditions

Idiopathic Parkinson's DiseaseParkinson's Disease

Phase 2

Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease

CompletedNCT00253084

Impax Laboratories, LLCParkinson's Disease

Start: 2005-11-30End: 2007-12-31Updated: 2019-10-29

Comparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's Disease

CompletedNCT00279825

Impax Laboratories, LLCIdiopathic Parkinson's Disease

Start: 2006-01-31End: 2007-12-31Updated: 2019-10-29

A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease

CompletedNCT02271503

Impax Laboratories, LLCParkinson's Disease

Start: 2015-11-30End: 2016-08-31Updated: 2019-11-06